147 related articles for article (PubMed ID: 31229033)
1. ANCA renal risk score predicts outcome in the Manchester cohort.
Li AS; Saleh C; Denley H; Patel M; Brix SR
Kidney Int; 2019 Jul; 96(1):246-247. PubMed ID: 31229033
[No Abstract] [Full Text] [Related]
2. ANCA comes of age-but with caveats.
Hamour SM; Salama AD
Kidney Int; 2011 Apr; 79(7):699-701. PubMed ID: 21403654
[TBL] [Abstract][Full Text] [Related]
3. Predictors of Renal Outcomes in Sclerotic Class Anti-Neutrophil Cytoplasmic Antibody Glomerulonephritis.
Menez S; Hruskova Z; Scott J; Cormican S; Chen M; Salama AD; Alasfar S; Little MA; Safrankova H; Honsova E; Tesar V; Geetha D
Am J Nephrol; 2018; 48(6):465-471. PubMed ID: 30472700
[TBL] [Abstract][Full Text] [Related]
4. ANCA-associated glomerulonephritis in the very elderly.
Bomback AS; Appel GB; Radhakrishnan J; Shirazian S; Herlitz LC; Stokes B; D'Agati VD; Markowitz GS
Kidney Int; 2011 Apr; 79(7):757-64. PubMed ID: 21160463
[TBL] [Abstract][Full Text] [Related]
5. Interstitial Immunostaining and Renal Outcomes in Antineutrophil Cytoplasmic Antibody-Associated Glomerulonephritis.
Geetha D; Sethi S; De Vriese AS; Specks U; Kallenberg CGM; Lim N; Spiera R; St Clair EW; Merkel PA; Seo P; Monach PA; Lepori N; Fessler BJ; Langford CA; Hoffman GS; Sharma R; Stone JH; Fervenza FC;
Am J Nephrol; 2017; 46(3):231-238. PubMed ID: 28881339
[TBL] [Abstract][Full Text] [Related]
6. Glomerular Immune Deposition in MPO-ANCA Associated Glomerulonephritis Is Associated With Poor Renal Survival.
Lin W; Shen C; Zhong Y; Ooi JD; Eggenhuizen P; Zhou YO; Luo H; Huang J; Chen JB; Wu T; Meng T; Xiao Z; Ao X; Peng W; Tang R; Yin H; Xiao X; Zhou Q; Xiao P
Front Immunol; 2021; 12():625672. PubMed ID: 33841408
[TBL] [Abstract][Full Text] [Related]
7. Clinical and histopathological prognostic factors affecting the renal outcomes in childhood ANCA-associated vasculitis.
Özçelik G; Sönmez HE; Şahin S; Özağarı A; Bayram MT; Çiçek RY; Çakıcı EK; Çomak E; Barut K; Şahin N; Bakkaloğlu S; Gökçe İ; Düzova A; Bilginer Y; Açarı C; Melek E; Kılıç BD; Özdel S; Adroviç A; Kasapçopur Ö; Ünsal E; Alpay H; Orhan D; Topaloğlu R; Düşünsel R; Özen S
Pediatr Nephrol; 2019 May; 34(5):847-854. PubMed ID: 30607566
[TBL] [Abstract][Full Text] [Related]
8. Prognostic Value of Microscopic Hematuria after Induction of Remission in Antineutrophil Cytoplasmic Antibodies-Associated Vasculitis.
Vandenbussche C; Bitton L; Bataille P; Glowacki F; Azar R; Hatron PY; Macnamara E; Gheerbrant JD; Cardon G; Hoffmann M; Auxenfants E; Gnemmi V; Quéméneur T
Am J Nephrol; 2019; 49(6):479-486. PubMed ID: 31117066
[TBL] [Abstract][Full Text] [Related]
9. Rituximab for treatment of severe renal disease in ANCA associated vasculitis.
Geetha D; Hruskova Z; Segelmark M; Hogan J; Morgan MD; Cavero T; Eriksson P; Seo P; Manno RL; Dale J; Harper L; Tesar V; Jayne DR
J Nephrol; 2016 Apr; 29(2):195-201. PubMed ID: 25986390
[TBL] [Abstract][Full Text] [Related]
10. Off-trial evaluation of the B cell-targeting treatment in the refractory cases of antineutrophil cytoplasmic antibodies (ANCA)-associated vasculitis: long-term follow-up from a single centre.
Pullerits R; Ljevak M; Vikgren J; Bokarewa M
Scand J Immunol; 2012 Oct; 76(4):411-20. PubMed ID: 22823472
[TBL] [Abstract][Full Text] [Related]
11. ANCA-positive pauci-immune rapidly progressive glomerulonephritis and the nephrotic syndrome.
Jabur WL; Saeed HM
Saudi J Kidney Dis Transpl; 2010 May; 21(3):526-30. PubMed ID: 20427883
[TBL] [Abstract][Full Text] [Related]
12. Patients double-seropositive for ANCA and anti-GBM antibodies have varied renal survival, frequency of relapse, and outcomes compared to single-seropositive patients.
McAdoo SP; Tanna A; Hrušková Z; Holm L; Weiner M; Arulkumaran N; Kang A; Satrapová V; Levy J; Ohlsson S; Tesar V; Segelmark M; Pusey CD
Kidney Int; 2017 Sep; 92(3):693-702. PubMed ID: 28506760
[TBL] [Abstract][Full Text] [Related]
13. A historical study of American patients with anti-neutrophil cytoplasmic antibody negative pauci-immune glomerulonephritis.
Shah S; Havill J; Rahman MH; Geetha D
Clin Rheumatol; 2016 Apr; 35(4):953-60. PubMed ID: 26445939
[TBL] [Abstract][Full Text] [Related]
14. On ANCA-associated glomerulonephritis in the very elderly.
Reschen ME
Kidney Int; 2011 Nov; 80(10):1107; author reply 1107. PubMed ID: 22042032
[No Abstract] [Full Text] [Related]
15. Pauci-immune glomerulonephritis: does negativity of anti-neutrophilic cytoplasmic antibodies matters?
Sharma A; Nada R; Naidu GS; Minz RW; Kohli HS; Sakhuja V; Gupta KL; Rathi M
Int J Rheum Dis; 2016 Jan; 19(1):74-81. PubMed ID: 26269223
[TBL] [Abstract][Full Text] [Related]
16. ANCA positive crescentic glomerulonephritis outcome in a Central East European cohort: a retrospective study.
Andreiana I; Stancu S; Avram A; Taran L; Mircescu G
BMC Nephrol; 2015 Jun; 16():90. PubMed ID: 26123651
[TBL] [Abstract][Full Text] [Related]
17. A cohort study to investigate sex-specific differences in ANCA-associated glomerulonephritis outcomes.
Scott J; Canepa C; Buettner A; Ryan L; Moloney B; Cormican S; Walsh C; White A; Salama AD; Little MA
Sci Rep; 2021 Jun; 11(1):13080. PubMed ID: 34158593
[TBL] [Abstract][Full Text] [Related]
18. L23. Renal transplantation in ANCA-associated vasculitis.
Segelmark M
Presse Med; 2013 Apr; 42(4 Pt 2):568-71. PubMed ID: 23453993
[No Abstract] [Full Text] [Related]
19. Antineutrophil cytoplasmic antibody negative pauci-immune extracapillary glomerulonephritis.
Villacorta J; Diaz-Crespo F; Acevedo M; Guerrero C; Mollejo M; Fernandez-Juarez G
Nephrology (Carlton); 2016 Apr; 21(4):301-7. PubMed ID: 26369898
[TBL] [Abstract][Full Text] [Related]
20. Manifest interstitial and vascular pathology in anti-neutrophil cytoplasmic antibody-associated renal disease.
Haridasan S; Ganesh RN; Parameswaran S; Priyamvada PS
Saudi J Kidney Dis Transpl; 2019; 30(3):726-734. PubMed ID: 31249242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
